CF
REGN icon

Centaurus Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Centaurus Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Hold
195
– – 0.01% 911
2025
Q4 		$151K Sell
195
-16
-8% -$10.9K 0.01% 899
2025
Q3 		$119K Buy
211
+9
+4% +$5.09K 0.01% 967
2025
Q2 		$106K Buy
202
+8
+4% +$4.46K 0.01% 929
2025
Q1 		$123K Sell
194
-2
-1% -$1.38K 0.01% 830
2024
Q4 		$140K Buy
196
+76
+63% +$63.8K 0.01% 778
2024
Q3 		$126K Buy
120
+8
+7% +$8.9K 0.01% 776
2024
Q2 		$118K Buy
+112
New +$109K 0.01% 743
2024
Q1 		– Sell
-117
Closed -$103K – 844
2023
Q4 		$103K Sell
117
-48
-29% -$39.5K 0.01% 751
2023
Q3 		$136K Buy
+165
New +$130K 0.01% 658
2022
Q4 		– Sell
-2,112
Closed -$1.46M – 900
2022
Q3 		$1.46M Buy
2,112
+5
+0.2% +$3.15K 0.14% 176
2022
Q2 		$1.25M Buy
2,107
+1
+0% +$650 0.12% 201
2022
Q1 		$1.47M Buy
2,106
+22
+1% +$13.9K 0.12% 213
2021
Q4 		$1.32M Buy
2,084
+684
+49% +$421K 0.1% 227
2021
Q3 		$847K Buy
1,400
+16
+1% +$9.93K 0.07% 301
2021
Q2 		$773K Buy
+1,384
New +$701K 0.07% 328
2019
Q2 		– Sell
-230
Closed -$559 – 628
2019
Q1 		$559 Buy
+230
New +$94.7K ﹤0.01% 546

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Centaurus Financial's REGN Position: Q1 2026 in Review

Centaurus Financial held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 195 shares worth $151K. The position accounts for 0.01% of the portfolio, ranked #911.

Centaurus Financial first reported a position in REGN in Q1 2019 and has held it in 17 quarters since. The position peaked at $1.47M in Q1 2022. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Centaurus Financial held 195 shares of Regeneron Pharmaceuticals worth $151K as of Q1 2026.
  • Centaurus Financial left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Centaurus Financial's portfolio in Q1 2026, its #911 holding.
  • Centaurus Financial first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
  • Centaurus Financial's Regeneron Pharmaceuticals position peaked at $1.47M in Q1 2022.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.